Chan Chao-Shun, Lin Feng-Zhi, Chen Yao-Chang, Higa Satoshi, Chen Shih-Ann, Chen Yi-Jen
Division of Cardiology, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Division of Cardiology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan.
J Cell Mol Med. 2025 Jun;29(12):e70664. doi: 10.1111/jcmm.70664.
Cigarette smoke includes nicotine that increases ventricular tachycardia (VT) risk. Chronic obstructive pulmonary disease (COPD) and right ventricular outflow tract (RVOT) constitute the primary risk factor and origin of VT, respectively. To investigate the arrhythmogenesis of nicotine in COPD, we employed tachypacing with or without H89, KN93 and KB-R7943 treatment, along with patch clamp experiments and Masson's trichrome staining in control rabbits and rabbits with human leukocyte elastase (0.3 unit/kg)-induced COPD. Following 20-Hz tachypacing and isoproterenol treatment, COPD RVOTs had a higher VT incidence than control RVOTs. Nicotine-treated COPD RVOTs had higher ventricular arrhythmogenesis than non-treated COPD RVOTs. VTs induced in COPD and nicotine-treated COPD RVOTs were suppressed by H89, KN93, or KB-R7943. COPD RVOT myocytes exhibited shorter action potentials than control RVOT myocytes; nicotine-treated COPD RVOT myocytes exhibited longer action potentials than COPD RVOT myocytes. Both COPD and nicotine-treated COPD myocytes had smaller L-type Ca currents and larger NCX currents than control RVOT myocytes. Nicotine-treated COPD RVOT myocytes had larger late Na currents than control and COPD RVOT myocytes. COPD and nicotine-treated COPD RVOTs exhibited more fibrosis. Nicotine-treated COPD RVOTs had the highest level of fibrosis. COPD intensifies RVOT VT through electrical and structural remodelling and Ca dysregulation through the activation of PKA, CaMKII and NCX signalling pathways. Nicotine further exacerbates VTs in the rabbit RVOT triggered by COPD.
香烟烟雾中含有尼古丁,会增加室性心动过速(VT)的风险。慢性阻塞性肺疾病(COPD)和右心室流出道(RVOT)分别是VT的主要危险因素和起源。为了研究尼古丁在COPD中的心律失常发生机制,我们对对照兔和用人白细胞弹性蛋白酶(0.3单位/千克)诱导COPD的兔进行了有或无H89、KN93和KB-R7943治疗的快速起搏,以及膜片钳实验和Masson三色染色。在20赫兹快速起搏和异丙肾上腺素治疗后,COPD RVOT的VT发生率高于对照RVOT。尼古丁处理的COPD RVOT的心室心律失常发生率高于未处理的COPD RVOT。H89、KN93或KB-R7943可抑制COPD和尼古丁处理的COPD RVOT中诱导的VT。COPD RVOT心肌细胞的动作电位比对照RVOT心肌细胞短;尼古丁处理的COPD RVOT心肌细胞的动作电位比COPD RVOT心肌细胞长。与对照RVOT心肌细胞相比,COPD和尼古丁处理的COPD心肌细胞的L型钙电流较小,钠钙交换电流(NCX)较大。尼古丁处理的COPD RVOT心肌细胞的晚期钠电流比对照和COPD RVOT心肌细胞大。COPD和尼古丁处理的COPD RVOT表现出更多的纤维化。尼古丁处理的COPD RVOT的纤维化程度最高。COPD通过电重构和结构重构以及通过激活蛋白激酶A(PKA)、钙调蛋白激酶II(CaMKII)和NCX信号通路导致钙调节异常,从而加剧RVOT VT。尼古丁进一步加重了由COPD引发的兔RVOT中的VT。